Oral Communications II: Inflammation & Cancer
Tracks
MC 2 Hall
| Wednesday, June 26, 2024 |
| 10:30 AM - 12:30 PM |
| MC2 Hall |
Speaker
Dr. Dubravka Svob Strac
Senior Research Associate, Head Of Laboratory
Rudjer Boskovic Institute
OC09. The Role of DHEA(s) in Dementia: Insights from Cellular and Animal Models and Human Patients
Prof. Ioannis Charalampopoulos
Professor
Medical School, University Of Crete & IMBB-FORTH
OC10. Dissecting the role of p75 pan-neurotrophin receptor in the hyperglycemia – induced neuropathology using a human iPSC-based model.
Dr. Szczepan Mogilski
Departament of Pharmacodynamics, Jagiellonian University Medical College
OC11. The selective positive allosteric modulator (PAM) of the glutamate transporter EAAT2 efficiently relieves pain and pruritus of different origins and potentiates opioid-induced analgesia
Dr. Anella Saviano
Phd Student
University of Naples Federico II
OC12. Design and biological characterization of new biologic (Ab-IPL-IL-17) for IL-17s-mediated diseases
Dr. Nadine Landolina
Tumor Immunology Unit, Bambino Gesù Children’s Hospital, IRCCS, 00146 Rome, Italy
OC13. The anti-inflammatory cytokine IL-37 plus IL-15 enhances human NK cells anti-tumor functions by interacting with IL-1R8
Prof. Evangelia Papadimitriou
University of Patras
OC14. Crizotinib inhibits mTORC1 activation, protein synthesis and endothelial cell activation by pleiotrophin or PTPRZ1 deletion
Dr. Kelly Ascencao
Lecturer
University Of Fribourg
OC16. Emerging roles of 3-MST in colon cancer
Prof. Samy Suissa
Distinguished James McGill Professor
Mcgill University
OC15. Observational studies of repurposing old drugs for new indications: The example of metformin to treat breast cancer
Chair
Ioannis Charalampopoulos
Professor
Medical School, University Of Crete & IMBB-FORTH
Csaba Szabo
Professor
University of Fribourg
